39 results
F-3ASR
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
of the provisions relating to covenant defeasance and legal defeasance;
additions to or changes in the provisions relating to satisfaction
F-3ASR
EX-4.4
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
of Redemption
Section 3.03
Payment Upon Redemption
Section 3.04
Sinking Fund
Section 3.05
Satisfaction of Sinking Fund Payments with Securities
Section … Indentures
ARTICLE 10 SUCCESSOR ENTITY
Section 10.01
Company May Consolidate, Etc.
Section 10.02
Successor Entity Substituted
ARTICLE 11 SATISFACTION
F-3ASR
EX-4.6
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
until such tax or other charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due.
(e
F-3ASR
EX-4.7
LEGN
Legend Biotech Corp
19 Mar 24
Automatic shelf registration (foreign)
7:57am
charge shall have been paid or it has been established to the Company’s satisfaction that no such tax or other charge is due.
(e) Prior
F-3ASR
EX-4.5
54o vgmkrlr1
26 May 23
Automatic shelf registration (foreign)
9:01am
F-3ASR
EX-4.6
ubonuc2eks b4
26 May 23
Automatic shelf registration (foreign)
9:01am
F-3ASR
EX-4.7
mnaqnyqtvz73i25wz
26 May 23
Automatic shelf registration (foreign)
9:01am
6-K
8l6gc56n459r6bvt 67w
8 May 23
Announces Pricing of Registered Direct Offering of US$350 million of American Depositary Shares
8:46am
6-K
EX-4.1
8mlyq7
8 May 23
Announces Pricing of Registered Direct Offering of US$350 million of American Depositary Shares
8:46am
424B5
m98a600eqre
8 May 23
Prospectus supplement for primary offering
8:45am
6-K
EX-99.1
kjfe7pdrg 22djgftrx3
16 Sep 22
Current report (foreign)
4:00pm
6-K
wscak7j
27 Jul 22
Announces Pricing of Public Offering
4:35pm
424B5
i3p d9qd4inw6
27 Jul 22
Prospectus supplement for primary offering
4:32pm
424B5
f7n3wompqrmwmdv8
25 Jul 22
Prospectus supplement for primary offering
4:29pm
6-K
qqq 0qvmpt4rh4
9 May 22
Legend Biotech Corporation 6-K
6:30am
6-K
vak8b8 k2
17 Dec 21
Announces Pricing of Public Offering
4:19pm
424B5
rs8v v5f00m2hhdz
17 Dec 21
Prospectus supplement for primary offering
4:16pm